X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (202) 202
microbiology (98) 98
animals (93) 93
microbiota (93) 93
bacteria (87) 87
humans (87) 87
firmicutes - isolation & purification (70) 70
firmicutes (67) 67
male (63) 63
firmicutes - genetics (60) 60
firmicutes - drug effects (58) 58
rna, ribosomal, 16s - genetics (57) 57
female (56) 56
gastrointestinal microbiome - drug effects (52) 52
gut microbiota (51) 51
analysis (47) 47
feces - microbiology (45) 45
mice (40) 40
metabolism (38) 38
microorganisms (38) 38
research (38) 38
diet (33) 33
diversity (33) 33
rrna 16s (33) 33
bacteroidetes - isolation & purification (32) 32
bacteroidetes - drug effects (31) 31
obesity (31) 31
health aspects (30) 30
anti-bacterial agents - pharmacology (29) 29
bacteria - classification (29) 29
intestine (28) 28
multidisciplinary sciences (28) 28
physiological aspects (28) 28
bacteroidetes (27) 27
phylogeny (27) 27
bacteria - genetics (26) 26
bacteroidetes - genetics (26) 26
firmicutes - growth & development (26) 26
antibiotics (25) 25
firmicutes - classification (25) 25
proteobacteria - isolation & purification (25) 25
research article (25) 25
digestive system (24) 24
intestinal microbiota (24) 24
proteins (24) 24
rats (24) 24
biochemistry & molecular biology (23) 23
biotechnology & applied microbiology (23) 23
gastrointestinal tract - microbiology (23) 23
inflammation (23) 23
studies (23) 23
adult (22) 22
bacteria - isolation & purification (22) 22
firmicutes - metabolism (22) 22
life sciences (22) 22
medicine (22) 22
mice, inbred c57bl (22) 22
abundance (21) 21
disease (21) 21
gastrointestinal microbiome - genetics (21) 21
proteobacteria - genetics (21) 21
article (20) 20
gastrointestinal microbiome (20) 20
rodents (20) 20
dna, bacterial - genetics (19) 19
fermentation (19) 19
metabolites (19) 19
microbiome (19) 19
probiotics (19) 19
sequence analysis, dna (19) 19
bacteria - drug effects (18) 18
biodiversity (18) 18
communities (18) 18
gene sequencing (18) 18
genes (18) 18
intestinal microflora (18) 18
science (18) 18
biotechnology (17) 17
digestive tract (17) 17
genomics (17) 17
health (17) 17
middle aged (17) 17
proteobacteria (17) 17
bacteroidetes - growth & development (16) 16
ecology (16) 16
microbiomes (16) 16
pharmacology & pharmacy (16) 16
rna (16) 16
biology and life sciences (15) 15
escherichia-coli (15) 15
high-throughput nucleotide sequencing (15) 15
inflammatory-bowel-disease (15) 15
proteobacteria - drug effects (15) 15
biological diversity (14) 14
dietary supplements (14) 14
gene expression (14) 14
medical microbiology (14) 14
microbiota - drug effects (14) 14
actinobacteria - isolation & purification (13) 13
bacterial proteins - genetics (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 03/2017, Volume 7, Issue 1, pp. 43412 - 43412
This study was conducted to investigate impacts of dietary protein levels on gut bacterial community and gut barrier. The intestinal microbiota of finishing... 
POSTWEANING DIARRHEA | HOST METABOLISM | CELLS | FINISHING PIGS | HOMEOSTASIS | PIGLETS | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | MODULATING INTESTINAL PERMEABILITY | BUTYRATE | PROMOTES | Dietary Proteins - administration & dosage | Peptostreptococcus - drug effects | Tight Junction Proteins - genetics | Receptors, G-Protein-Coupled - metabolism | Colon - drug effects | Ileum - metabolism | Escherichia - metabolism | Escherichia - classification | Fatty Acids, Volatile - metabolism | Intestinal Mucosa - drug effects | Occludin - metabolism | Genetic Variation | Polycomb Repressive Complex 1 - genetics | Dietary Proteins - metabolism | Ileum - drug effects | Swine | Shigella - metabolism | Tight Junction Proteins - metabolism | Firmicutes - isolation & purification | Intestinal Mucosa - microbiology | Peptostreptococcus - isolation & purification | Colon - metabolism | Gastrointestinal Microbiome - drug effects | Claudin-1 - genetics | Escherichia - drug effects | Receptors, G-Protein-Coupled - genetics | Escherichia - isolation & purification | Firmicutes - drug effects | Animal Feed | Peptostreptococcus - classification | Intestinal Mucosa - metabolism | Polycomb Repressive Complex 1 - metabolism | Shigella - classification | Gastrointestinal Microbiome - physiology | Clostridium - isolation & purification | Shigella - drug effects | Clostridium - classification | Occludin - genetics | Claudin-1 - metabolism | Biogenic Amines - metabolism | Diet, Protein-Restricted - methods | Firmicutes - metabolism | Digestion - drug effects | Firmicutes - classification | Shigella - isolation & purification | Peptostreptococcus - metabolism | Digestion - physiology | Gene Expression Regulation - drug effects | Animals | Clostridium - metabolism | Colon - microbiology | Ileum - microbiology | Clostridium - drug effects | Amines | Digestive system | Mucosa | Ileum | Studies | Proteins | Protein composition | Metabolites | Intestine | Fish | Intestinal microflora | Colon | Digestive tract | Biogenic amines | Colonization | Index Medicus
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 09/2015, Volume 42, Issue 5, pp. 515 - 528
Journal Article
Diabetes, ISSN 0012-1797, 09/2018, Volume 67, Issue 9, pp. 1867 - 1879
Intermittent fasting (IF) protects against the development of metabolic diseases and cancer, but whether it can prevent diabetic microvascular complications is... 
DIABETIC-RETINOPATHY | BILE-ACID | CELLS | ACTIVATION | BACTERIA | OBESITY | METABOLISM | FARNESOID X RECEPTOR | C57BL/6 MICE | ENDOCRINOLOGY & METABOLISM | TAUROURSODEOXYCHOLIC ACID | Retina - drug effects | Leukocytes - pathology | Receptors, G-Protein-Coupled - metabolism | Colon - drug effects | Microvessels - metabolism | Microvessels - pathology | Colon - immunology | Male | Ganglia, Sensory - metabolism | Retina - immunology | Intestinal Mucosa - drug effects | Diabetic Retinopathy - complications | Retinal Vessels - pathology | Feces - microbiology | Intestinal Mucosa - immunology | Bacteroidetes - isolation & purification | Firmicutes - growth & development | Diabetic Retinopathy - immunology | Firmicutes - isolation & purification | Retinal Vessels - metabolism | Colon - pathology | Retinal Vessels - drug effects | Dysbiosis - therapy | Goblet Cells - metabolism | Colon - metabolism | Ganglia, Sensory - pathology | Diabetic Retinopathy - prevention & control | Gastrointestinal Microbiome - drug effects | Bile Acids and Salts - therapeutic use | Survival Analysis | Leukocytes - drug effects | Diabetes Mellitus, Type 2 - pathology | Dysbiosis - pathology | Retina - pathology | Intestinal Mucosa - pathology | Intestinal Mucosa - metabolism | Retina - metabolism | Diabetes Mellitus, Type 2 - microbiology | Ganglia, Sensory - drug effects | Goblet Cells - drug effects | Diabetic Retinopathy - pathology | Receptors, G-Protein-Coupled - agonists | Dysbiosis - microbiology | Microvessels - immunology | Ganglia, Sensory - immunology | Goblet Cells - immunology | Leukocytes - immunology | Retinal Vessels - immunology | Mice, Mutant Strains | Diabetes Mellitus, Type 2 - therapy | Bacteroidetes - immunology | Mice, Inbred DBA | Verrucomicrobia - growth & development | Verrucomicrobia - immunology | Diabetes Mellitus, Type 2 - complications | Fasting | Microvessels - drug effects | Firmicutes - immunology | Verrucomicrobia - isolation & purification | Dysbiosis - complications | Animals | Bacteroidetes - growth & development | Gastrointestinal Microbiome - immunology | Goblet Cells - pathology | Prevention | Diabetic retinopathy | Usage | Diet therapy | Low-calorie diet | Rattus | Rats | Health aspects | Neuroprotection | Retinopathy | Diabetes mellitus | Peptidoglycans | Microbiomes | Retina | mRNA | Tumor necrosis factor-α | Feeding | Microbiota | Mucin | Metabolites | Cell number | Rodents | Hemoglobin | Microvasculature | Diabetes | Capillaries | Ganglion cells | Bile | Cancer | Index Medicus | Abridged Index Medicus | Complications | 0107
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 03/2019, Volume 124, pp. 931 - 937
is a traditional medicinal plant used in most Asian countries to cure many diseases. The benefits of ginseng are due to its primary active component,... 
Gut microbiota | Polysaccharides | Antibiotic-associated diarrhea | Panax ginseng | POLYMER SCIENCE | PECTIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | COMMUNITIES | INHIBITION | SAPONINS | DIVERSITY | CHEMISTRY, APPLIED | MULTIVARIATE ANALYSES | MODULATION | Carbohydrate Metabolism - drug effects | Plant Extracts - chemistry | Gastric Mucosa - microbiology | Proteobacteria - metabolism | Dysbiosis - drug therapy | Male | Proteobacteria - classification | Phylogeny | Diarrhea - chemically induced | Dysbiosis - microbiology | Actinobacteria - drug effects | Amino Acids - metabolism | Antidiarrheals - pharmacology | Diarrhea - microbiology | Polysaccharides - isolation & purification | Gastric Mucosa - drug effects | Actinobacteria - metabolism | Actinobacteria - isolation & purification | Firmicutes - metabolism | Bacteroidetes - isolation & purification | Lincomycin - administration & dosage | Dysbiosis - chemically induced | Firmicutes - isolation & purification | Actinobacteria - classification | Bacteroidetes - drug effects | Firmicutes - classification | Bacteroidetes - classification | Proteobacteria - drug effects | Polysaccharides - pharmacology | Dysbiosis - metabolism | Animals | Gastrointestinal Microbiome - drug effects | Panax - chemistry | Proteobacteria - isolation & purification | Bacteroidetes - metabolism | Antidiarrheals - isolation & purification | Diarrhea - metabolism | Diarrhea - drug therapy | Mice | Mice, Inbred BALB C | Firmicutes - drug effects | Anti-Bacterial Agents - administration & dosage | Energy Metabolism - drug effects | Index Medicus
Journal Article
Journal of Nutrition, ISSN 0022-3166, 2017, Volume 147, Issue 5, pp. 770 - 780
Background: The consumption of a Western-style diet (WSD) and high fructose intake are risk factors for metabolic diseases. The underlying mechanisms are... 
Western-style diet | Permeability | Defensin | Gut microbiome | Fructose | HIGH-FAT | BACTERIA | BIFIDOBACTERIA | permeability | PRIMERS | fructose | NONALCOHOLIC STEATOHEPATITIS | INSULIN SENSITIVITY | REAL-TIME PCR | OBESITY | NUTRITION & DIETETICS | gut microbiome | defensin | DISEASE | MODULATION | Defensins - metabolism | Intestinal Mucosa - metabolism | Bacteria - drug effects | Colon - drug effects | Ileum - metabolism | Dietary Carbohydrates - metabolism | Bifidobacterium - growth & development | Fructose - metabolism | Intestinal Mucosa - drug effects | Bacteria - growth & development | Ileum - drug effects | Dietary Fats - pharmacology | Fructose - pharmacology | Dietary Fats - administration & dosage | Female | Mucus - metabolism | RNA, Ribosomal, 16S | Weight Gain | Diet, Western | Drinking Water - administration & dosage | Dietary Carbohydrates - administration & dosage | Endotoxins - metabolism | Firmicutes - growth & development | Dietary Carbohydrates - pharmacology | Mice, Inbred C57BL | Feeding Behavior | Bacteroidetes - drug effects | Intestinal Mucosa - microbiology | Colon - metabolism | Bifidobacterium - drug effects | Animals | Gastrointestinal Microbiome - drug effects | Bacteroidetes - growth & development | Firmicutes - drug effects | Dietary Supplements | Fructose - administration & dosage | Metabolic diseases | Physiological research | Microbiota (Symbiotic organisms) | Health aspects | Risk factors | Access control | Drinking water | rRNA 16S | Lactulose | Body weight | Mucus | Gene sequencing | Microorganisms | Intestine | Rodents | Mannitol | Colon | Digestive tract | Sugar | Translocation | Carbohydrates | Digestive system | Weight gain measurement | Health risks | Risk analysis | Body weight gain | Ileum | Diet | Mice | Metabolic disorders | Index Medicus
Journal Article
Journal Article
Journal Article
Applied and Environmental Microbiology, ISSN 0099-2240, 2016, Volume 82, Issue 22, pp. 6633 - 6644
Besides being part of anti-Helicobacter pylori treatment regimens, proton pump inhibitors (PPIs) are increasingly being used to treat dyspepsia. However,... 
COMMUNITY-ACQUIRED PNEUMONIA | PYROSEQUENCING METHODS | FUNCTIONAL DYSPEPSIA | HELICOBACTER-PYLORI INFECTION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GASTROINTESTINAL-TRACT | BACTERIAL MICROBIOTA | RISK | MICROBIOLOGY | HUMAN STOMACH | GUT MICROBIOTA | CANCER | Gastric Mucosa - microbiology | Humans | Middle Aged | Firmicutes - genetics | Helicobacter pylori - drug effects | Proteobacteria - classification | Proteobacteria - genetics | Anti-Bacterial Agents - therapeutic use | Streptococcus - classification | Streptococcus - isolation & purification | Helicobacter Infections - drug therapy | Gastric Mucosa - drug effects | Bacteria - classification | Adult | Female | Bacteroidetes - isolation & purification | Proton Pump Inhibitors - adverse effects | Dyspepsia - drug therapy | Omeprazole - therapeutic use | Firmicutes - isolation & purification | Dyspepsia - microbiology | Firmicutes - classification | Bacteroidetes - classification | Gastrointestinal Microbiome - genetics | Proton Pump Inhibitors - therapeutic use | Bacteria - genetics | Bacteria - isolation & purification | Gastrointestinal Microbiome - drug effects | Proteobacteria - isolation & purification | Streptococcus - genetics | RNA, Ribosomal, 16S - genetics | Aged | Genes, rRNA | High-Throughput Nucleotide Sequencing | Bacteroidetes - genetics | Helicobacter Infections - microbiology | Microbiota (Symbiotic organisms) | Dyspepsia | Physiological aspects | Proton pump inhibitors | Influence | Research | Health aspects | Bacteria | Inhibitor drugs | Microbiology | Ribonucleic acid--RNA | Gastrointestinal diseases | Medical treatment | Index Medicus
Journal Article
PLoS One, ISSN 1932-6203, 07/2016, Volume 11, Issue 6, pp. e0156836 - e0156836
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2017, Volume 61, Issue 12
Pexiganan, a cationic peptide, exhibited a broad range of anti-anaerobic antimicrobial activity. The MIC90s of studied isolates were as follows: Bacteroides... 
Pexiganan | Finegoldia magna | Anaerobes | Topical antimicrobials | Bacteroides fragilis | Propionibacterium acnes | Clostridia | Wound infections | clostridia | BACTERIOLOGY | pexiganan | wound infections | DIABETIC FOOT INFECTIONS | topical antimicrobials | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | anaerobes | Peptostreptococcus - drug effects | Skin - microbiology | Porphyromonas - drug effects | Propionibacterium acnes - growth & development | United States | Humans | Bacteroides fragilis - drug effects | Actinobacteria - drug effects | Clostridium perfringens - isolation & purification | Fusobacterium - drug effects | Microbial Sensitivity Tests | Skin Diseases, Infectious - microbiology | Sweden | Prevotella - growth & development | Bacteroides fragilis - growth & development | Actinobacteria - isolation & purification | Porphyromonas - isolation & purification | Fusobacterium - growth & development | Skin - pathology | Firmicutes - growth & development | Amino Acid Sequence | Antimicrobial Cationic Peptides - chemical synthesis | Anaerobiosis - physiology | Firmicutes - isolation & purification | Skin Diseases, Infectious - pathology | Antimicrobial Cationic Peptides - pharmacology | Peptostreptococcus - isolation & purification | Prevotella - drug effects | Anti-Bacterial Agents - chemical synthesis | Bacteroides fragilis - isolation & purification | Canada | Clostridium perfringens - drug effects | Peptostreptococcus - growth & development | Clostridium perfringens - growth & development | Actinobacteria - growth & development | Propionibacterium acnes - isolation & purification | Anti-Bacterial Agents - pharmacology | Porphyromonas - growth & development | Firmicutes - drug effects | Prevotella - isolation & purification | Propionibacterium acnes - drug effects | Fusobacterium - isolation & purification | Index Medicus
Journal Article